These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 3484535)

  • 1. Distribution of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in experimental animals studied by postiron emission tomography and whole body autoradiography.
    Hartvig P; Lindquist NG; Aquilonius SM; d'Argy R; Bergström K; Bondesson U; Eckernäs SA; Gullberg P; Larsson BS; Lindberg B
    Life Sci; 1986 Jan; 38(1):89-97. PubMed ID: 3484535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of monoamine oxidase inhibitors and a dopamine uptake blocker on the distribution of 11C-N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, 11C-MPTP, in the head of the rhesus monkey.
    Hartvig P; Larsson BS; Lindberg BS; Oreland L; Gullberg P; Långström B; Rimland A; Lundqvist H; Malmborg P; Lindquist NG
    Acta Neurol Scand; 1986 Jul; 74(1):10-6. PubMed ID: 3490110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoradiography of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): uptake in the monoaminergic pathways and in melanin containing tissues.
    Lydén A; Bondesson U; Larsson BS; Lindquist NG; Olsson LI
    Acta Pharmacol Toxicol (Copenh); 1985 Aug; 57(2):130-5. PubMed ID: 3877403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disposition of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in mice before and after monoamine oxidase and catecholamine reuptake inhibition.
    Lydén-Sokolowski A; Larsson BS; Lindquist NG
    Pharmacol Toxicol; 1988 Aug; 63(2):75-80. PubMed ID: 3141911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of 1-(3H)-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (3H-MPTP) in the frog: uptake in neuromelanin.
    Sokolowski AL; Larsson BS; Lindquist NG
    Pharmacol Toxicol; 1990 Apr; 66(4):252-8. PubMed ID: 2371232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regional cerebral pharmacokinetics of the dopaminergic neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine as examined by positron emission tomography in a baboon is altered by tranylcypromine.
    Moerlein SM; Stöcklin G; Pawlik G; Wienhard K; Heiss WD
    Neurosci Lett; 1986 May; 66(2):205-9. PubMed ID: 3487753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies on the effect of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on central catecholamine neurons in C57BL/6 mice. Comparison with three other strains of mice.
    Sundström E; Strömberg I; Tsutsumi T; Olson L; Jonsson G
    Brain Res; 1987 Mar; 405(1):26-38. PubMed ID: 2882814
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of MPTP on Serotonergic Neuronal Systems and Mitochondrial Complex I Activity in the Living Brain: A PET Study on Conscious Rhesus Monkeys.
    Kanazawa M; Ohba H; Nishiyama S; Kakiuchi T; Tsukada H
    J Nucl Med; 2017 Jul; 58(7):1111-1116. PubMed ID: 28280215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity.
    Javitch JA; D'Amato RJ; Strittmatter SM; Snyder SH
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):2173-7. PubMed ID: 3872460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in local cerebral glucose utilization associated with Parkinson's syndrome induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the primate.
    Porrino LJ; Burns RS; Crane AM; Palombo E; Kopin IJ; Sokoloff L
    Life Sci; 1987 Apr; 40(17):1657-64. PubMed ID: 3494179
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective accumulation of MPP+ in the substantia nigra: a key to neurotoxicity?
    Irwin I; Langston JW
    Life Sci; 1985 Jan; 36(3):207-12. PubMed ID: 3871240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP.
    Tanji H; Araki T; Nagasawa H; Itoyama Y
    Brain Res; 1999 Apr; 824(2):224-31. PubMed ID: 10196452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1-Methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine (2'-CH3-MPTP) is a more potent dopaminergic neurotoxin than MPTP in mice.
    Youngster SK; Duvoisin RC; Hess A; Sonsalla PK; Kindt MV; Heikkila RE
    Eur J Pharmacol; 1986 Mar; 122(2):283-7. PubMed ID: 3486770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent protein binding of a metabolite of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine to mouse and monkey brain in vitro and in vivo.
    Corsini GU; Bocchetta A; Zuddas A; Piccardi MP; Del Zompo M
    Biochem Pharmacol; 1988 Nov; 37(21):4163-9. PubMed ID: 3263863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unilateral MPTP lesion in a rhesus monkey: effects on the striatal dopaminergic system measured in vivo with PET using various novel tracers.
    Leenders KL; Aquilonius SM; Bergström K; Bjurling P; Crossman AR; Eckernas SA; Gee AG; Hartvig P; Lundqvist H; Långström B
    Brain Res; 1988 Mar; 445(1):61-7. PubMed ID: 3259152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS; Markey SP; Phillips JM; Chiueh CC
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dopamine in the extrapyramidal motor function. A study based upon the MPTP-induced primate model of parkinsonism.
    Chiueh CC
    Ann N Y Acad Sci; 1988; 515():226-38. PubMed ID: 3259118
    [No Abstract]   [Full Text] [Related]  

  • 19. Early signs of neuronal apoptosis in the substantia nigra pars compacta of the progressive neurodegenerative mouse 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine/probenecid model of Parkinson's disease.
    Novikova L; Garris BL; Garris DR; Lau YS
    Neuroscience; 2006 Jun; 140(1):67-76. PubMed ID: 16533572
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.
    Imai H; Nakamura T; Endo K; Narabayashi H
    Brain Res; 1988 Dec; 474(2):327-32. PubMed ID: 3264746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.